|
Market Closed -
CBOE
09:00:00 21/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 131.66 EUR | +2.36% |
|
-0.29% | +21.49% |
| 18/09 | Dr. Reddy's Confirms License for Gilead's Yearly-Once HIV Drug; Shares Up 2% | MT |
| 17/09 | Gilead Sciences Insider Sold Shares Worth $432,646, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Gilead Sciences, Inc.(GILD)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Gilead Sciences, Inc.(GILD)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Gilead Sciences, Inc.(GILD)
EBIT
Dividend / Share (DPS)
Data source:
Gilead Sciences, Inc.(GILD)
Cash or Net Debt
- Stock Market
- Stocks
- GILD Stock
- Stock
- Consensus Gilead Sciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
